Proton beam therapy for downstaging hepatocellular carcinoma with lobar portal vein tumor thrombosis to living donor liver transplantation  

作　　者：Chao-Long Chen Leona Bettina PDungca Chee-Chien Yong Itsuko Chih-Yi Chen Yu-Fan Cheng Jen-Yu Cheng Yen-Yang Chen 

机构地区：[1]Liver Transplantation Center,Department of Surgery,Kaohsiung Chang Gung Memorial Hospital,Chang Gung University College of Medicine,Kaohsiung [2]Liver Transplantation Center,Department of Diagnostic Radiology,Kaohsiung Chang Gung Memorial Hospital,Chang Gung University College of Medicine,Kaohsiung [3]Liver Transplantation Center,Department of Radiation Oncology,Kaohsiung Chang Gung Memorial Hospital,Chang Gung University College of Medicine,Kaohsiung [4]Liver Transplantation Center,Department of Hematology-Oncology,Kaohsiung Chang Gung Memorial Hospital,Chang Gung University College of Medicine,Kaohsiung

出　　处：《Hepatobiliary Surgery and Nutrition》2023年第6期966-974,共9页肝胆外科与营养（英文）

摘　　要：Introduction Liver transplantation(LT)is considered as the definitive standard treatment for hepatocellular carcinoma(HCC)with the advantage of addressing both malignancy and the underlying cirrhosis,thus,providing the best overall and recurrence-free survival.Unfortunately,only 20-25%of patients meet the eligibility criteria for LT.

关 键 词：Proton beam therapy(PBT) hepatocellular carcinoma(HCC) portal vein tumor thrombosis(PVTT) living donor liver transplantation(LDLT) downstaging therapy 

分 类 号：R735.7[医药卫生—肿瘤]